Prezent Vivo and Nested Knowledge have announced a strategic partnership designed to streamline how pharmaceutical and biotechnology organizations gather, synthesize, and act on competitive intelligence.
The collaboration combines two complementary technologies. Prezent Vivo provides an AI-powered business communication platform enhanced by human expertise, while Nested Knowledge offers automated evidence synthesis through its AutoLit® platform.
Together, the companies aim to solve a common challenge faced by life sciences organizations: converting massive amounts of scientific and competitive information into actionable insights that can support decision-making.
The integrated solution is expected to help organizations prepare for major medical congresses, monitor evolving scientific evidence, and respond more quickly to competitive developments.
A key differentiator is the combination of automation and human expertise. Nested Knowledge’s AutoLit engine can complete rapid literature reviews in less than 30 minutes and reduce systematic review timelines by more than 70%. Prezent Vivo then transforms those findings into communication assets and intelligence deliverables tailored to the needs of different teams.
The companies say this approach eliminates the need for organizations to manually consolidate information from multiple sources before preparing strategic recommendations.
“As trusted communications partners to leading life sciences organizations, we saw a recurring challenge,” said Francine Carrick, President of Prezent Vivo. “Critical evidence existed, but it was not always being translated into formats teams could quickly use.”
The partnership will provide several services, including congress intelligence packages, monthly living evidence updates, on-demand competitive analyses, and customized deliverables for medical affairs, HEOR, market access, and commercial teams.
One of the first major use cases will be support for organizations attending leading scientific congresses. The partnership launches ahead of a busy conference season that includes ASCO, EHA, ISTH, and other major medical meetings.
Participating organizations will receive intelligence briefings before events begin, followed by synthesis packages that translate newly released data into actionable business implications.
According to Keith Kallmes, President of Nested Knowledge, the partnership addresses a longstanding gap between evidence generation and organizational execution.
“Rapid and rigorous literature synthesis already exists,” Kallmes said. “What has been missing is the translation layer that turns that synthesis into action.”
The companies also emphasize that the solution is designed to operate beyond individual events. Monthly living evidence updates will provide continuously refreshed summaries of emerging research, allowing organizations to track developments throughout the year without repeatedly commissioning new reviews.
Industry observers increasingly view this type of integrated AI deployment as the next phase of digital transformation in life sciences. Rather than implementing isolated tools, organizations are seeking connected workflows that combine data collection, analysis, synthesis, and communication in a single process.
Prezent Vivo CEO and Co-Founder Rajat Mishra believes this approach represents the future of scientific communication.
“Extraordinary impact comes from combining AI speed with human expertise,” Mishra said. “This partnership enables life sciences teams to move from evidence to action faster than ever before.”
As competition intensifies across pharmaceutical and biotechnology markets, solutions that shorten the distance between information and decision-making are becoming increasingly valuable. Prezent Vivo and Nested Knowledge are positioning themselves at the center of that trend.